Related Experiment Video
Updated: Aug 15, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Emerging infections in transfusion medicine
Eberhard W Fiebig1, Michael P Busch
1Department of Laboratory Medicine, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA. fiebig@itsa.ucsf.edu
Transfusion-transmitted infectious diseases (TTIDs) risk has decreased due to preventing established viruses. Focus now shifts to emerging pathogens like West Nile virus, infectious proteins, bacteria, and parasites in blood transfusions.
Area of Science:
- Blood Transfusion Safety
- Infectious Disease Epidemiology
- Public Health
Background:
- Transfusion-transmitted infectious diseases (TTIDs) risk has significantly decreased in high-income countries over 20 years.
- Successes include preventing HIV and other established transfusion-transmitted viruses from entering the blood supply.
Purpose of the Study:
- To address the ongoing public health concern of TTIDs.
- To refocus attention on new and emerging pathogens that pose a threat to blood transfusion safety.
- To review existing and evolving procedures for protecting the blood supply.
Main Methods:
- Review of emerging pathogens and their risks in transfusion recipients.
- Analysis of current and developing procedures to safeguard the blood supply.
- Concentration on a heterogeneous group of infectious agents, including viruses, infectious proteins, bacteria, and parasites.
Main Results:
- While established TTIDs are reduced, emerging pathogens like West Nile virus, infectious proteins (e.g., variant Creutzfeldt-Jakob disease), bacteria, and parasites remain a concern.
- Individual pathogens and their specific risks to transfusion recipients are described.
- Existing and evolving protective procedures are commented upon.
Conclusions:
- TTIDs, particularly from novel and emerging agents, continue to pose a threat to transfusion recipients.
- Ongoing vigilance and evolving strategies are crucial for maintaining blood supply safety.
- Protecting the blood supply requires a comprehensive approach to diverse infectious agents.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

